Richard R. Furman

Also affiliated with Presbyterian Hospital, Weill Cornell Medicine

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 10 papers. Top paper: “Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia”.

Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia

New England Journal of Medicine(2013)10.1056/nejmoa1215637

N/A

18.9DataRank · unranked

2265 citations

Richard R. Furman, Steven E. Coutre, Ian W. Flinn, Jan A. Burger, Kristie A. Blum +16 more

Outcomes of COVID-19 in patients with CLL: a multicenter international experience

Blood(2020)10.1182/blood.2020006965

N/A

13.4DataRank · unranked

318 citations

Lindsey E. Roeker, Nicole Lamanna, John N. Allan, Lori A. Leslie, John M. Pagel +57 more

Ibrutinib Treatment for First-Line and Relapsed/Refractory Chronic Lymphocytic Leukemia: Final Analysis of the Pivotal Phase Ib/II PCYC-1102 Study

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-2856

N/A

4.5DataRank · unranked

184 citations

Richard R. Furman, Steven Coutré, Ian W. Flinn, Jan A. Burger, Kristie A. Blum +9 more

Venetoclax for patients with chronic lymphocytic leukemia who progressed during or after idelalisib therapy

Blood(2018)10.1182/blood-2017-06-788133

N/A

0.734DataRank · unranked

132 citations

Michael Choi, Richard R. Furman, Herbert Eradat, Leonard Heffner, Jeffrey A. Jones +10 more

Polygenic risk score and risk of monoclonal B-cell lymphocytosis in caucasians and risk of chronic lymphocytic leukemia (CLL) in African Americans

Leukemia(2021)10.1038/s41375-021-01344-9

N/A

0.726DataRank · unranked

22 citations

J. Brice Weinberg, Sameer A. Parikh, Esteban Braggio, Sara J. Achenbach, Dennis P. Robinson +17 more

Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis

Blood Advances(2024)10.1182/bloodadvances.2023012242

N/A

0.330DataRank · unranked

8 citations

Nicholas Boddicker, Daniel R. O’Brien, Cristine Allmer, Kari G. Rabe, Aaron D. Norman +23 more

Comprehensive comparison of enzymatic and bisulfite DNA methylation analysis in clinically relevant samples

Clinical Epigenetics(2025)10.1186/s13148-025-01959-0

N/A

0.292DataRank · unranked

6 citations

Daniel L. Karl, Kathleen Burke, Megan Callahan, Kerrin Mendler, Pablo Cingolani +13 more

Genomic characterization of chronic lymphocytic leukemia in patients of African ancestry

Blood Cancer Journal(2025)10.1038/s41408-024-01207-3

N/A

0DataRank · unranked

3 citations

Chantal E. McCabe, Laura A. Bruins, Daniel O’Brien, Sochilt Brown, Renee C. Tschumper +16 more

Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies

Journal of Clinical Investigation(2023)10.1172/jci170169

N/A

0DataRank · unranked

43 citations

Fen Zhu, Olga Dashevsky, Rin Mizuno, Jolin Xiao Hui Lai, Liam Hackett +19 more

Serologic response to mRNA COVID‐19 vaccination in lymphoma patients

American Journal of Hematology(2021)10.1002/ajh.26322

N/A

0DataRank · unranked

27 citations

Thomas J. Ketas, Zhen Zhao, Michael J. Satlin, Catherine B. Small, Ashley Sukhu +11 more